Publications by authors named "Magda Barinova"

Claim this Profile
L
Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?
Monika Bratova, Kristian Brat, Karolina Hurdalkova, Magda Barinova, Marie Drosslerova

J Adolesc Young Adult Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Jana Skrickova, Milos Pesek, Petr Opalka, Leona Koubkova, Milada Zemanova, Magda Barinova

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.
Roman Hájek, Jiří Minařík, Jan Straub, Luděk Pour, Alexandra Jungova

Future Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory Parameters are Possible Prognostic Markers in Patients with Advanced-stage NSCLC Treated with Bevacizumab plus Chemotherapy.
Martin Svaton, Jiri Blazek, Gabriela Krakorova, Marcela Buresova, Zuzana Teufelova, Magda Barinova

J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Daniel Krejci, Petr Opalka, Jana Krejci, Milada Zemanova, Petra Zemanova, Magda Barinova

Anticancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy.
Martin Svaton, Jiri Blazek, Gabriela Krakorova, Milos Pesek, Marcela Buresova, Magda Barinova

Anticancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life Effectiveness of Afatinib Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study.
Martin Svaton, Monika Bratova, Ondrej Fischer, Jana Krejci, Leona Koubkova, Magda Barinova

Anticancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
Kristian Brat, Monika Bratova, Jana Skrickova, Magda Barinova, Karolina Hurdalkova

Thorac Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib.
Martin Svaton, Ondrej Fiala, Gabriela Krakorova, Jiri Blazek, Karolina Hurdalkova, Magda Barinova

Oncol Lett· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry.
Monika Bratova, Bara Karlinova, Jana Skrickova, Milos Pesek, Vitezslav Kolek, Magda Barinova

In Vivo· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.
Martin Svaton, Milada Zemanova, Petra Zemanova, Juraj Kultan, Ondrej Fischer, Magda Barinova

Anticancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis